INJE PharmacoGenomics Research Center

· Phat NK, Tien NTM, Anh NK, Yen NTH, Lee YA, Trinh HKT, Le KM, Ahn SZ, Cho YS, Park SO, Kim DH, Long NP, Shin JG

Alterations of lipid-related genes during anti-tuberculosis treatment: insights into host immune responses and potential transcriptional biomarkers (cPMTb)

Front Immunol. 31:14:1210372 / 2023.10 [LINK]

· Ahn SZ

A use case of ChatGPT in a flipped medical terminology course (cPMTb)

Korean J Med Educ. 35(3):303-307 / 2023.09 [LINK]

· Jarrar Y, Abudahab S, Abdul-Wahab G, Zaiter D, Madani A, Abaalkhail SJ, Abulebdah D, Alhawari H, Musleh R, Lee SJ

Clinical Significance of NAT2 Genetic Variations in Type II Diabetes Mellitus and Lipid Regulation (cPMTb)

Pharmgenomics Pers Med. 13:16:847-857 / 2023.09 [LINK]

· Duong TH, Vu YT, Long NP, Phan NHN, Pham NKT, Sichaem J, Kieu NKD, Duong CB, Nguyen TT, Dang VS, Nguyen HT

Bioactive-Guided Phytochemical Investigations, In Vitro and In Silico Alpha-Glucosidase Inhibition of Two Vietnamese Medicinal Plants Dicranopteris linearis and Psychotria adenophylla (cPMTb)

Pharmaceuticals(Basel). 5;16(9):1253 / 2023.09 [LINK]

· Ghim JL, Ahn SZ

Transforming clinical trials: the emerging roles of large language models (cPMTb)

Transl Clin Pharmacol. 31(3):131-138 / 2023.09 [LINK]

· Nhung TTM, Long NP, Nghi TD, Suh YJ, Anh NH, Jung CW, Triet HM, Jung MK, Woo YS, Yoo JY, Noh SJ, Kim SJ, Lee SB, Park SO, Thomas G, Simmen T, Mun JY, Rhee RW, Kwon SW, Park SK

Genome-wide kinase-MAM interactome screening reveals the role of CK2A1 in MAM Ca2+ dynamics linked to DEE66 (cPMTb)

Proc Natl Acad Sci U S A. 8;120(32):e2303402120 / 2023.08 [LINK]

· Yen NTH, Phat NK, Oh JH, Park SM, Moon KS, Thu VTA, Cho YS, Shin JG, Long NP, Kim DH

Pathway-level multi-omics analysis of the molecular mechanisms underlying the toxicity of long-term tacrolimus exposure (cPMTb)

Toxicol Appl Pharmacol. 15:473:116597 / 2023.08 [LINK]

· Hung TM, Jayanti RP, Lee HY, Kim HJ, Mok JH, Jang TW, Oh JY, Kim JS, Ko YS, Min JS, Hoa PQ, Ahn SZ, Long NP, Cho YS, Shin JG, cPMTb

Recommendation of pharmacokinetics/pharmacodynamics target of ethambutol to suppress tuberculosis resistance: A population pharmacokinetics study on a large prospective cohort (cPMTb)

Int J Antimicrob Agents. 62(2):106840 / 2023.08 [LINK]

· Yen NTH, Anh NK, Jayanti RP, Phat NK, Vu DH, Ghim JL, Ahn SZ, Shin JG, Oh JY, Long NP, Kim DH

Multimodal plasma metabolomics and lipidomics in elucidating metabolic perturbations in tuberculosis patients with concurrent type 2 diabetes (cPMTb)

Biochimie. 211:153-163 / 2023.08 [LINK]

· Nguyen BT, Yen NTH, Tung NKT, Jeong GS, Kang JS, Long NP, Kim HM

Lipid class-dependent alterations of Caenorhabditis elegans under harmane exposure (cPMTb)

J Pharm Biomed Anal. 5:231:115401 / 2023.07 [LINK]

Publications

Product